GFS
RGLS

GYL Financial Synergies’s Regulus Therapeutics RGLS Stock Holding History

GYL Financial Synergies’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,400
Closed -$10K – 206
2022
Q1 		$10K Sell
3,400
-700
-17% -$1.82K ﹤0.01% 203
2021
Q4 		$13K Hold
4,100
– – ﹤0.01% 209
2021
Q3 		$28K Hold
4,100
– – 0.01% 188
2021
Q2 		$33K Sell
4,100
-1,038
-20% -$11.6K 0.02% 183
2021
Q1 		$80K Hold
5,138
– – 0.04% 177
2020
Q4 		$69K Buy
+5,138
New +$37.7K 0.04% 170

Other funds holding RGLS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return